Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dídac Llop

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Revista Espanola De Salud Publica|August 12, 2021
[Defined daily doses in drugs with combinations of active principles: differences between three calculation methods.]Carles Llop Margalef, Dídac Llop Paredes, Maria Guinovart Moncunill
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 30, 2025
Plasma expression of a microRNA panel is differentially associated with 1H-NMR lipoprotein profile in rheumatoid arthritis patientsDídac Llop, Silvia Paredes, Roser Rosales, et al.
Scientific Reports|August 3, 2021
Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patientsDelia Taverner, Dídac Llop, Roser Rosales, et al.
Scientific Reports|November 3, 2024
Comprehensive analysis of glycoprotein profiles and their association with cardiovascular disease-related microRNAs in rheumatoid arthritis, metabolic disorders, and controlsDídac Llop, Silvia Paredes, Roser Rosales, et al.
Computational and Structural Biotechnology Journal|May 1, 2024
Angiopoietin-2, vascular endothelial growth factor family, and heparin binding endothelial growth factor are associated with subclinical atherosclerosis in rheumatoid arthritisAnna Pàmies, Dídac Llop, Daiana Ibarretxe, et al.
Frontiers in Immunology|October 24, 2025
Atherosclerotic cardiovascular disease and mortality in a cohort of patients with rheumatoid arthritis: a prospective study investigating microRNAs as predictors of atherosclerosis and mortalityDídac Llop, Silvia Paredes, Daiana Ibarretxe, et al.
International Journal of Molecular Sciences|September 28, 2024
Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis PatientsAnna Pàmies, Dídac Llop, Daiana Ibarretxe, et al.
International Journal of Molecular Sciences|October 28, 2023
Plasma Expression of Carotid Plaque Presence-Related MicroRNAs Is Associated with Inflammation in Patients with Rheumatoid ArthritisDídac Llop, Silvia Paredes, Daiana Ibarretxe, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2022
Glycoprotein Serum Concentrations Assessed By 1H-NMR are Increased in Patients With High Blood PressureNatalia Andreychuk, Dídac Llop, Juan Moreno-Vedia, et al.
Autoimmunity Reviews|September 13, 2024
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysisJavier Narváez, Martí Aguilar-Coll, Montserrat Roig-Kim, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Revista Espanola De Salud Publica|August 12, 2021
[Defined daily doses in drugs with combinations of active principles: differences between three calculation methods.]Carles Llop Margalef, Dídac Llop Paredes, Maria Guinovart Moncunill
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|January 30, 2025
Plasma expression of a microRNA panel is differentially associated with 1H-NMR lipoprotein profile in rheumatoid arthritis patientsDídac Llop, Silvia Paredes, Roser Rosales, et al.
Scientific Reports|August 3, 2021
Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patientsDelia Taverner, Dídac Llop, Roser Rosales, et al.
Scientific Reports|November 3, 2024
Comprehensive analysis of glycoprotein profiles and their association with cardiovascular disease-related microRNAs in rheumatoid arthritis, metabolic disorders, and controlsDídac Llop, Silvia Paredes, Roser Rosales, et al.
Computational and Structural Biotechnology Journal|May 1, 2024
Angiopoietin-2, vascular endothelial growth factor family, and heparin binding endothelial growth factor are associated with subclinical atherosclerosis in rheumatoid arthritisAnna Pàmies, Dídac Llop, Daiana Ibarretxe, et al.
Frontiers in Immunology|October 24, 2025
Atherosclerotic cardiovascular disease and mortality in a cohort of patients with rheumatoid arthritis: a prospective study investigating microRNAs as predictors of atherosclerosis and mortalityDídac Llop, Silvia Paredes, Daiana Ibarretxe, et al.
International Journal of Molecular Sciences|September 28, 2024
Enhanced Association of Novel Cardiovascular Biomarkers Fetuin-A and Catestatin with Serological and Inflammatory Markers in Rheumatoid Arthritis PatientsAnna Pàmies, Dídac Llop, Daiana Ibarretxe, et al.
International Journal of Molecular Sciences|October 28, 2023
Plasma Expression of Carotid Plaque Presence-Related MicroRNAs Is Associated with Inflammation in Patients with Rheumatoid ArthritisDídac Llop, Silvia Paredes, Daiana Ibarretxe, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2022
Glycoprotein Serum Concentrations Assessed By 1H-NMR are Increased in Patients With High Blood PressureNatalia Andreychuk, Dídac Llop, Juan Moreno-Vedia, et al.
Autoimmunity Reviews|September 13, 2024
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysisJavier Narváez, Martí Aguilar-Coll, Montserrat Roig-Kim, et al.
Pageof 2